Quick Answer
REGENEREX PHARMA, INC. reported Total Revenue of $1.8 thousand for the year ending 2021.
- REGENEREX PHARMA, INC. showed a decrease of -31.9% in Total Revenue from 2020 to 2021.
- This data is from REGENEREX PHARMA, INC.'s annual report (Form 10-K), filed with the SEC on June 23, 2021.
- XBRL data for this metric is available from 2020 to 2021 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2014: $9.2 thousand | Q4 2019: $1.7 thousand | Q2 2020: $77.00 | Q3 2020: $120.00 | Q4 2020: $181.00.
- Historical annual values: Fiscal year 2021: $1.8 thousand | Fiscal year 2020: $2.6 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: